On 2026-11-10, Hemab Therapeutics Holdings, Inc. (COAG) announced earnings per share of $-0.58 for the fiscal quarter ending 2026-09-30, missing the average analyst estimate of $-0.51.
The next expected annoucement date for quarterly earnings is 2027-02-09, with an average estimated earnings per share of $-0.59 for the fiscal quarter ending 2026-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-11-10 | 2026-09-30 | $-0.51 | $-0.58 |
| 2026-08-11 | 2026-06-30 | $-0.63 | $-0.80 |
| 2026-05-21 | 2026-03-31 | -- | $-23.98 |